尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Porter Derrell. Insider active across 1 company, notably Acumen Pharmaceuticals, Inc.. Aggregated, 7 disclosures have been published. Split: 0 buy · 3 sells. History available since 4 June 2025. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Porter Derrell is a declarant linked to Acumen Pharmaceuticals, Inc. (XNAS), where he is a director. The record includes 6 filings, and the sampled recent filings run from 2026-06-05 to 2026-06-17, with reported buy and sell volumes of 0 EUR and a dominant transaction nature of sale.